https://xintela.se/en/mfn_news/newsletter-july-2019/ 2025-11-20T16:32:09+00:00 https://xintela.se/mfn_news/bokslutskommunike-2019-01-01-till-2019-12-31/ 2025-11-20T16:32:08+00:00 https://xintela.se/en/mfn_news/xintela-publishes-positive-preclinical-results-from-equine-study/ 2025-11-20T16:32:08+00:00 https://xintela.se/mfn_news/xintela-offentliggor-arsredovisning-for-2019/ 2025-11-20T16:32:08+00:00 https://xintela.se/mfn_news/xintela-sakrar-ytterligare-finansiering-upptar-lan-om-189-miljoner-kronor-med-konverteringsmojlighet/ 2025-11-20T16:32:08+00:00 https://xintela.se/mfn_news/kallelse-till-arsstamma-i-xintela-ab-publ-6/ 2025-11-20T16:32:08+00:00 https://xintela.se/en/mfn_news/xintela-granted-1-million-sek-from-vinnova/ 2025-11-20T16:32:08+00:00 https://xintela.se/mfn_news/xintela-beviljas-1-miljon-kronor-fran-vinnova/ 2025-11-20T16:32:08+00:00 https://xintela.se/mfn_news/xintela-ab-arsstamma-nytt-datum-for-stamman/ 2025-11-20T16:32:08+00:00 https://xintela.se/en/mfn_news/xintela-granted-2-million-sek-from-vinnova/ 2025-11-20T16:32:08+00:00 https://xintela.se/mfn_news/xintela-beviljas-2-miljoner-kronor-fran-vinnova/ 2025-11-20T16:32:08+00:00 https://xintela.se/mfn_news/xintela-erhaller-preliminart-godkannande-av-europapatentverket-for-behandling-av-tumorer-i-hjarnan/ 2025-11-20T16:32:07+00:00 https://xintela.se/en/mfn_news/xintela-granted-preliminary-approval-from-the-european-patent-office-for-the-treatment-of-brain-tumors/ 2025-11-20T16:32:07+00:00 https://xintela.se/mfn_news/xintela-erhaller-teckningsatagande-om-cirka-3-msek-fran-bauerfeind-group-i-bolagets-fullt-garanterade-foretradesemission-om-cirka-37-msek/ 2025-11-20T16:32:07+00:00 https://xintela.se/en/mfn_news/xintela-develops-treatment-for-aggressive-breast-cancer/ 2025-11-20T16:32:07+00:00 https://xintela.se/mfn_news/xintela-utvecklar-behandling-for-aggressiv-brostcancer/ 2025-11-20T16:32:07+00:00 https://xintela.se/mfn_news/xintela-avser-genomfora-fullt-garanterad-foretradesemission-av-units-om-cirka-37-msek/ 2025-11-20T16:32:07+00:00 https://xintela.se/mfn_news/kommunike-fran-xintelas-arsstamma-2020/ 2025-11-20T16:32:07+00:00 https://xintela.se/mfn_news/xintela-offentliggor-delarsrapport-for-forsta-kvartalet-2020/ 2025-11-20T16:32:07+00:00 https://xintela.se/mfn_news/xintelas-fullt-garanterade-foretradesemission-av-units-kraftigt-overtecknad-utnyttjar-utokningsoptionen/ 2025-11-20T16:32:07+00:00 https://xintela.se/mfn_news/xintela-offentliggor-prospekt-avseende-fullt-garanterad-foretradesemission-av-units-om-cirka-37-msek/ 2025-11-20T16:32:07+00:00 https://xintela.se/en/mfn_news/xintela-receives-intention-to-grant-decision-from-european-patent-office-for-stem-cell-product-xstem/ 2025-11-20T16:32:06+00:00 https://xintela.se/en/mfn_news/xintela-applies-for-tissue-establishment-license/ 2025-11-20T16:32:06+00:00 https://xintela.se/mfn_news/xintela-ansoker-om-tillstand-for-vavnadsinrattning/ 2025-11-20T16:32:06+00:00 https://xintela.se/mfn_news/xintelas-stamceller-visar-lovande-resultat-i-preklinisk-ards-studie/ 2025-11-20T16:32:06+00:00 https://xintela.se/en/mfn_news/xintelas-stem-cells-show-promising-results-in-preclinical-ards-study/ 2025-11-20T16:32:06+00:00 https://xintela.se/mfn_news/xintela-offentliggor-delarsrapport-for-andra-kvartalet-2020/ 2025-11-20T16:32:06+00:00 https://xintela.se/en/mfn_news/xintela-expands-and-strengthens-management-team/ 2025-11-20T16:32:06+00:00 https://xintela.se/mfn_news/xintela-utokar-och-forstarker-ledningen/ 2025-11-20T16:32:06+00:00 https://xintela.se/mfn_news/xintela-erhaller-notice-of-allowance-fran-uspto-for-kvalitetssakring-av-broskcellsbaserade-produkter/ 2025-11-20T16:32:06+00:00 https://xintela.se/en/mfn_news/xintela-receives-notice-of-allowance-from-uspto-for-quality-assurance-of-chondrocyte-based-products/ 2025-11-20T16:32:06+00:00 https://xintela.se/mfn_news/nyhetsbrev-november-2020/ 2025-11-20T16:32:05+00:00 https://xintela.se/mfn_news/nulagesanalys-av-xintela-publicerad/ 2025-11-20T16:32:05+00:00 https://xintela.se/en/mfn_news/status-report-of-xintela-published/ 2025-11-20T16:32:05+00:00 https://xintela.se/mfn_news/xintela-erhaller-preliminart-godkannande-av-europapatentverket-for-sin-stamcellsprodukt-xstem/ 2025-11-20T16:32:05+00:00 https://xintela.se/en/mfn_news/xintela-publishes-interim-report-for-the-third-quarter-of-2020/ 2025-11-20T16:32:05+00:00 https://xintela.se/mfn_news/xintela-ab-offentliggor-utfallet-av-nyttjandet-av-teckningsoptioner-av-serie-to-2/ 2025-11-20T16:32:05+00:00 https://xintela.se/mfn_news/xintelas-styrelse-foreslar-lars-hedbys-som-ny-styrelseledamot/ 2025-11-20T16:32:05+00:00 https://xintela.se/en/mfn_news/xintela-board-recommends-lars-hedbys-as-new-board-member/ 2025-11-20T16:32:05+00:00 https://xintela.se/en/mfn_news/newsletter-november-2020/ 2025-11-20T16:32:05+00:00 https://xintela.se/mfn_news/losenpris-faststallt-avseende-teckningsoptioner-av-serie-to-2-i-xintela-ab-dar-teckningsperioden-inleds-den-4-november-2020/ 2025-11-20T16:32:05+00:00 https://xintela.se/mfn_news/nyhetsbrev-fran-xintela-december-2020/ 2025-11-20T16:32:04+00:00 https://xintela.se/en/mfn_news/xintela-submits-manufacturing-license-application/ 2025-11-20T16:32:04+00:00 https://xintela.se/mfn_news/xintela-skickar-in-ansokan-om-tillverkningstillstand/ 2025-11-20T16:32:04+00:00 https://xintela.se/en/mfn_news/xintela-recruits-jeffrey-abbey-to-targinta/ 2025-11-20T16:32:04+00:00 https://xintela.se/mfn_news/xintela-rekryterar-jeffrey-abbey-till-targinta/ 2025-11-20T16:32:04+00:00 https://xintela.se/en/mfn_news/arbitral-award-rendered-in-favour-of-xintela-in-dispute-with-former-underwriters/ 2025-11-20T16:32:04+00:00 https://xintela.se/mfn_news/skiljedom-meddelad-till-xintelas-fordel-i-tvist-med-tidigare-garanter/ 2025-11-20T16:32:04+00:00 https://xintela.se/en/mfn_news/xintela-board-recommends-maarten-de-chateau-as-new-board-member/ 2025-11-20T16:32:04+00:00 https://xintela.se/mfn_news/xintelas-styrelse-foreslar-maarten-de-chateau-som-ny-styrelseledamot/ 2025-11-20T16:32:04+00:00 https://xintela.se/mfn_news/xintela-offentliggor-delarsrapport-for-tredje-kvartalet-2020/ 2025-11-20T16:32:04+00:00 https://xintela.se/en/mfn_news/xintela-gets-patent-grant-in-europe-for-xstem-stem-cell-product/ 2025-11-20T16:32:03+00:00 https://xintela.se/mfn_news/xintela-erhaller-godkant-patent-i-europa-for-sin-stamcellsprodukt-xstem/ 2025-11-20T16:32:03+00:00 https://xintela.se/en/mfn_news/xintela-publishes-results-from-glioblastoma-antibody-study/ 2025-11-20T16:32:03+00:00 https://xintela.se/mfn_news/xintela-publicerar-antikroppsresultat-fran-glioblastomstudie/ 2025-11-20T16:32:03+00:00 https://xintela.se/en/mfn_news/year-end-report-1-jan-31-dec-2020/ 2025-11-20T16:32:03+00:00 https://xintela.se/mfn_news/bokslutskommunike-2020-01-01-till-2020-12-31/ 2025-11-20T16:32:03+00:00 https://xintela.se/en/mfn_news/newsletter-december-2020/ 2025-11-20T16:32:03+00:00 https://xintela.se/mfn_news/rattelse-uppdatering-tidigare-pressmeddelande-xintela-ab-har-genomfort-en-kvittningsemission-av-aktier-om-95-msek/ 2025-11-20T16:32:03+00:00 https://xintela.se/mfn_news/xintela-ab-har-genomfort-en-kvittningsemission-av-aktier-om-95-msek/ 2025-11-20T16:32:03+00:00 https://xintela.se/mfn_news/xintela-erhaller-notice-of-allowance-fran-uspto-for-behandling-av-tumorer-i-hjarnan/ 2025-11-20T16:32:03+00:00 https://xintela.se/en/mfn_news/xintela-receives-notice-of-allowance-from-uspto-for-the-treatment-of-brain-tumors/ 2025-11-20T16:32:03+00:00 https://xintela.se/mfn_news/kallelse-till-arsstamma-i-xintela-ab-publ-5/ 2025-11-20T16:32:02+00:00 https://xintela.se/mfn_news/xintela-rapporterar-positiva-resultat-fran-preklinisk-ards-studie-och-erhaller-nytt-anslag-om-23-miljoner-kronor/ 2025-11-20T16:32:02+00:00 https://xintela.se/en/mfn_news/xintela-reports-positive-results-from-preclinical-ards-study-and-new-grant-of-2-3-million-sek/ 2025-11-20T16:32:02+00:00 https://xintela.se/en/mfn_news/xintela-gets-tissue-establishment-license/ 2025-11-20T16:32:02+00:00 https://xintela.se/en/mfn_news/xintelas-gmp-facility-approved-for-manufacturing-of-cell-therapy-products/ 2025-11-20T16:32:02+00:00 https://xintela.se/mfn_news/xintela-erhaller-tillstand-for-vavnadsinrattning/ 2025-11-20T16:32:02+00:00 https://xintela.se/mfn_news/xintelas-gmp-anlaggning-erhaller-tillstand-att-producera-cellterapiprodukter/ 2025-11-20T16:32:02+00:00 https://xintela.se/en/mfn_news/xintela-to-develop-stem-cell-therapy-for-difficult-to-heal-wounds/ 2025-11-20T16:32:02+00:00 https://xintela.se/mfn_news/xintela-utvecklar-stamcellsbehandling-for-svarlakta-sar/ 2025-11-20T16:32:02+00:00 https://xintela.se/mfn_news/xintelas-stamcellsprodukt-xstem-reparerar-skadat-ledbrosk-i-preklinisk-modell/ 2025-11-20T16:32:02+00:00 https://xintela.se/en/mfn_news/xintelas-stem-cell-product-xstem-repairs-cartilage-damage-in-preclinical-model/ 2025-11-20T16:32:02+00:00 https://xintela.se/mfn_news/kommunike-fran-xintelas-arsstamma-2021/ 2025-11-20T16:32:02+00:00 https://xintela.se/mfn_news/targinta-rekryterar-per-norlen-som-vd/ 2025-11-20T16:32:02+00:00 https://xintela.se/en/mfn_news/targinta-recruits-per-norlen-as-ceo/ 2025-11-20T16:32:02+00:00 https://xintela.se/mfn_news/xintela-offentliggor-arsredovisning-for-2020/ 2025-11-20T16:32:02+00:00 https://xintela.se/mfn_news/inspektion-av-xintelas-gmp-verksamhet-for-tillverkningstillstand-genomford/ 2025-11-20T16:32:02+00:00 https://xintela.se/en/mfn_news/xintela-gmp-inspection-for-manufacturing-license-completed/ 2025-11-20T16:32:02+00:00 https://xintela.se/en/mfn_news/xintela-has-completed-a-directed-new-share-issue-raising-proceeds-of-approximately-sek-28-million/ 2025-11-20T16:32:01+00:00 https://xintela.se/en/mfn_news/xintela-intends-to-carry-out-a-directed-share-issue-through-an-accelerated-book-building-procedure/ 2025-11-20T16:32:01+00:00 https://xintela.se/mfn_news/xintela-avser-att-genomfora-en-riktad-nyemission-av-aktier-genom-ett-accelererat-bookbuilding-forfarande/ 2025-11-20T16:32:01+00:00 https://xintela.se/mfn_news/xintela-offentliggor-delarsrapport-for-forsta-kvartalet-2021/ 2025-11-20T16:32:01+00:00 https://xintela.se/mfn_news/xintela-tecknar-avtal-med-australiensisk-cro-for-klinisk-studie/ 2025-11-20T16:32:01+00:00 https://xintela.se/mfn_news/narmare-kliniska-studier/ 2025-11-20T16:32:01+00:00 https://xintela.se/mfn_news/kommunike-fran-extra-bolagsstamma-i-xintela-2/ 2025-11-20T16:32:01+00:00 https://xintela.se/en/mfn_news/xintela-incorporates-subsidiary-in-australia/ 2025-11-20T16:32:01+00:00 https://xintela.se/mfn_news/xintela-bildar-dotterbolag-i-australien/ 2025-11-20T16:32:01+00:00 https://xintela.se/mfn_news/kallelse-till-extra-bolagsstamma-i-xintela-ab/ 2025-11-20T16:32:01+00:00 https://xintela.se/mfn_news/xintela-har-genomfort-en-riktad-nyemission-av-aktier-och-tillfors-darigenom-cirka-28-msek/ 2025-11-20T16:32:01+00:00 https://xintela.se/mfn_news/xintela-breddar-klinisk-utveckling-av-stamcellsprodukten-xstem/ 2025-11-20T16:32:00+00:00 https://xintela.se/en/mfn_news/xintela-half-year-report-2021-01-01-2021-06-30/ 2025-11-20T16:32:00+00:00 https://xintela.se/mfn_news/halvarsrapport-2021-01-01-2021-06-30/ 2025-11-20T16:32:00+00:00 https://xintela.se/en/mfn_news/closing-in-on-our-next-major-milestone/ 2025-11-20T16:32:00+00:00 https://xintela.se/en/mfn_news/xintela-signs-with-australian-cro-for-clinical-study/ 2025-11-20T16:32:00+00:00 https://xintela.se/mfn_news/xintela-tar-eqstem-en-stamcellsprodukt-for-hastar-mot-marknaden/ 2025-11-20T16:31:59+00:00 https://xintela.se/en/mfn_news/targinta-selects-lead-drug-candidate-for-triple-negative-breast-cancer/ 2025-11-20T16:31:59+00:00 https://xintela.se/mfn_news/targinta-valjer-lakemedelskandidat-for-trippelnegativ-brostcancer/ 2025-11-20T16:31:59+00:00 https://xintela.se/en/mfn_news/xintela-to-expand-clinical-development-of-stem-cell-product-xstem/ 2025-11-20T16:31:59+00:00 https://xintela.se/en/mfn_news/xintela-and-scanvet-animal-health-a-s-sign-letter-of-intent/ 2025-11-20T16:31:59+00:00 https://xintela.se/mfn_news/xintela-och-scanvet-animal-health-a-s-tecknar-letter-of-intent/ 2025-11-20T16:31:59+00:00 https://xintela.se/mfn_news/xintela-ab-delarsrapport-januari-september-2021/ 2025-11-20T16:31:59+00:00 https://xintela.se/en/mfn_news/xintela-ab-interim-report-january-september-2021/ 2025-11-20T16:31:59+00:00 https://xintela.se/mfn_news/xintela-erhaller-lan-om-9-msek/ 2025-11-20T16:31:59+00:00 https://xintela.se/en/mfn_news/update-on-status-and-strategy-for-xintela-and-targinta/ 2025-11-20T16:31:59+00:00 https://xintela.se/mfn_news/uppdatering-av-xintelas-och-targintas-status-och-strategi/ 2025-11-20T16:31:59+00:00 https://xintela.se/en/mfn_news/new-board-of-directors-appointed-in-targinta-ab/ 2025-11-20T16:31:59+00:00 https://xintela.se/mfn_news/ny-styrelse-har-utsetts-i-targinta-ab/ 2025-11-20T16:31:59+00:00 https://xintela.se/en/mfn_news/xintela-taking-eqstem-a-stem-cell-product-for-horses-towards-the-market/ 2025-11-20T16:31:59+00:00 https://xintela.se/mfn_news/xintela-erhaller-48-miljoner-kronor-fran-vinnova/ 2025-11-20T16:31:58+00:00 https://xintela.se/en/mfn_news/xintela-granted-4-8-million-sek-from-vinnova/ 2025-11-20T16:31:58+00:00 https://xintela.se/mfn_news/kommunike-fran-extra-bolagsstamma-i-xintela/ 2025-11-20T16:31:58+00:00 https://xintela.se/mfn_news/nyhetsbrev-fran-xintela-januari-2022/ 2025-11-20T16:31:58+00:00 https://xintela.se/en/mfn_news/xintela-newsletter-january-2022/ 2025-11-20T16:31:58+00:00 https://xintela.se/mfn_news/kallelse-till-extra-bolagsstamma-i-xintela-ab-publ-3/ 2025-11-20T16:31:58+00:00 https://xintela.se/en/mfn_news/xintela-starts-clinical-study-of-xstem-in-knee-osteoarthritis/ 2025-11-20T16:31:58+00:00 https://xintela.se/mfn_news/xintela-startar-klinisk-studie-med-xstem-for-knaartros/ 2025-11-20T16:31:58+00:00 https://xintela.se/en/mfn_news/english-version-of-press-release-2022-03-21-xintela-ab-announced-that-the-company-received-a-loan-of-sek-3-million/ 2025-11-20T16:31:58+00:00 https://xintela.se/mfn_news/xintela-ab-meddelar-idag-att-bolaget-erhaller-ett-lan-om-3-msek/ 2025-11-20T16:31:58+00:00 https://xintela.se/en/mfn_news/xintela-ab-year-end-report-january-december-2021/ 2025-11-20T16:31:58+00:00 https://xintela.se/mfn_news/xintela-ab-avger-bokslutskommunike-for-2021/ 2025-11-20T16:31:58+00:00 https://xintela.se/en/mfn_news/xintela-proposes-hans-joachim-simons-as-new-board-member/ 2025-11-20T16:31:57+00:00 https://xintela.se/mfn_news/xintela-foreslar-hans-joachim-simons-som-ny-styrelseledamot/ 2025-11-20T16:31:57+00:00 https://xintela.se/mfn_news/xintela-abs-arsredovisning-2021-publicerad/ 2025-11-20T16:31:57+00:00 https://xintela.se/en/mfn_news/xintela-abs-annual-report-2021-published/ 2025-11-20T16:31:57+00:00 https://xintela.se/en/mfn_news/targinta-presents-new-preclinical-data-on-targ10-at-the-aacr-annual-meeting/ 2025-11-20T16:31:57+00:00 https://xintela.se/mfn_news/targinta-presenterar-nya-prekliniska-data-for-targ10-vid-aacr-annual-meeting/ 2025-11-20T16:31:57+00:00 https://xintela.se/en/mfn_news/notice-of-annual-general-meeting-in-xintela-ab-publ/ 2025-11-20T16:31:57+00:00 https://xintela.se/mfn_news/kallelse-till-arsstamma-i-xintela-ab-publ-4/ 2025-11-20T16:31:57+00:00 https://xintela.se/en/mfn_news/targinta-selects-adc-antibody-targ9-as-drug-candidate/ 2025-11-20T16:31:57+00:00 https://xintela.se/mfn_news/targinta-utser-adc-antikroppen-targ9-till-ny-lakemedelskandidat/ 2025-11-20T16:31:57+00:00 https://xintela.se/en/mfn_news/xintela-publishes-results-showing-that-xstem-repairs-damaged-joint-cartilage-in-preclinical-model/ 2025-11-20T16:31:53+00:00 https://xintela.se/mfn_news/xintela-publicerar-resultat-som-visar-att-xstem-reparerar-skadat-ledbrosk-i-preklinisk-modell/ 2025-11-20T16:31:53+00:00 https://xintela.se/en/mfn_news/notice-from-annual-general-meeting-in-xintela-ab-publ/ 2025-11-20T16:31:53+00:00 https://xintela.se/mfn_news/kommunike-fran-arsstamma-i-xintela-ab-publ-4/ 2025-11-20T16:31:53+00:00 https://xintela.se/mfn_news/xintela-offentliggor-utfall-i-foretradesemissionen-och-beslutar-om-riktad-nyemission-om-10-msek/ 2025-11-20T16:31:52+00:00 https://xintela.se/en/mfn_news/xintela-receives-approval-for-clinical-study-with-xstem-on-difficult-to-heal-venous-leg-ulcers/ 2025-11-20T16:31:52+00:00 https://xintela.se/mfn_news/xintela-erhaller-godkannande-for-klinisk-studie-med-xstem-pa-svarlakta-venosa-bensar/ 2025-11-20T16:31:52+00:00 https://xintela.se/mfn_news/xintela-offentliggor-prospekt-med-anledning-av-forestaende-foretradesemission-2/ 2025-11-20T16:31:52+00:00 https://xintela.se/mfn_news/xintela-meddelar-tidplan-for-kapitalanskaffning/ 2025-11-20T16:31:52+00:00 https://xintela.se/en/mfn_news/targinta-obtains-patent-grant-in-japan/ 2025-11-20T16:31:52+00:00 https://xintela.se/mfn_news/targinta-beviljas-patent-i-japan/ 2025-11-20T16:31:52+00:00 https://xintela.se/en/mfn_news/targinta-engages-abzena-for-the-production-of-targ9-and-targ10/ 2025-11-20T16:31:52+00:00 https://xintela.se/mfn_news/targinta-anlitar-abzena-for-produktion-av-targ9-och-targ10/ 2025-11-20T16:31:52+00:00 https://xintela.se/en/mfn_news/xintela-ab-interim-report-january-march-2022/ 2025-11-20T16:31:52+00:00 https://xintela.se/mfn_news/xintela-ab-delarsrapport-januari-mars-2022/ 2025-11-20T16:31:52+00:00 https://xintela.se/mfn_news/xintela-genomfor-en-kapitalanskaffning-som-inkluderar-en-fullt-garanterad-foretradesemission-om-cirka-446-msek-samt-en-kompletterande-riktad-emission-om-upp-till-10-msek/ 2025-11-20T16:31:52+00:00 https://xintela.se/en/mfn_news/per-norlen-to-step-down-as-targinta-ceo/ 2025-11-20T16:31:52+00:00 https://xintela.se/mfn_news/per-norlen-kommer-att-sluta-som-vd-for-targinta/ 2025-11-20T16:31:52+00:00 https://xintela.se/mfn_news/kallelse-till-extra-bolagsstamma-i-xintela-ab-publ-2/ 2025-11-20T16:31:52+00:00 https://xintela.se/mfn_news/xintela-har-genomfort-doseringen-pa-forsta-dosnivan-av-xstem-i-den-kliniska-studien-for-knaartros/ 2025-11-20T16:31:51+00:00 https://xintela.se/en/mfn_news/targinta-appoints-peter-ekolind-as-acting-ceo/ 2025-11-20T16:31:51+00:00 https://xintela.se/mfn_news/targinta-utser-peter-ekolind-till-tillforordnad-vd/ 2025-11-20T16:31:51+00:00 https://xintela.se/en/mfn_news/xintela-starts-clinical-study-with-xstem-for-difficult-to-heal-leg-ulcers/ 2025-11-20T16:31:51+00:00 https://xintela.se/mfn_news/xintela-startar-klinisk-studie-med-xstem-for-svarlakta-bensar/ 2025-11-20T16:31:51+00:00 https://xintela.se/en/mfn_news/targinta-presents-positive-preclinical-data-on-the-antibody-drug-conjugate-targ9/ 2025-11-20T16:31:51+00:00 https://xintela.se/mfn_news/targinta-presenterar-positiva-prekliniska-data-for-adc-antikroppen-targ9/ 2025-11-20T16:31:51+00:00 https://xintela.se/mfn_news/uttalande-fran-styrelsen-for-xintela-med-anledning-av-flerie-invest-abs-budpliktsbud/ 2025-11-20T16:31:51+00:00 https://xintela.se/en/mfn_news/xintela-ab-interim-report-january-june-2022/ 2025-11-20T16:31:51+00:00 https://xintela.se/mfn_news/xintela-ab-delarsrapport-januari-juni-2022/ 2025-11-20T16:31:51+00:00 https://xintela.se/mfn_news/kommunike-fran-extra-bolagsstamma-i-xintela-ab-publ-2/ 2025-11-20T16:31:51+00:00 https://xintela.se/mfn_news/xintela-sakrar-finansiering-om-25-miljoner-kronor-och-beslutar-om-en-riktad-emission-av-konvertibler/ 2025-11-20T16:31:50+00:00 https://xintela.se/en/mfn_news/xintela-completes-dosing-of-xstem-first-dose-level-in-knee-osteoarthritis-clinical-study/ 2025-11-20T16:31:50+00:00 https://xintela.se/mfn_news/xintela-ab-delarsrapport-januari-september-2022/ 2025-11-20T16:31:50+00:00 https://xintela.se/en/mfn_news/targinta-plans-phase-0-clinical-study/ 2025-11-20T16:31:50+00:00 https://xintela.se/mfn_news/targinta-planerar-for-klinisk-fas-0-studie/ 2025-11-20T16:31:50+00:00 https://xintela.se/en/mfn_news/xintela-starts-next-dose-level-of-xstem-in-knee-osteoarthritis-clinical-study/ 2025-11-20T16:31:50+00:00 https://xintela.se/mfn_news/xintela-startar-nasta-dosniva-av-xstem-i-klinisk-studie-for-knaartros/ 2025-11-20T16:31:50+00:00 https://xintela.se/en/mfn_news/xintela-proposes-thomas-eldered-as-new-board-member/ 2025-11-20T16:31:50+00:00 https://xintela.se/mfn_news/xintela-foreslar-thomas-eldered-som-ny-styrelseledamot/ 2025-11-20T16:31:50+00:00 https://xintela.se/mfn_news/kallelse-till-extra-bolagsstamma-i-xintela-ab-publ/ 2025-11-20T16:31:50+00:00 https://xintela.se/en/mfn_news/xintela-newsletter-december-2022/ 2025-11-20T16:31:49+00:00 https://xintela.se/mfn_news/nyhetsbrev-fran-xintela-december-2022/ 2025-11-20T16:31:49+00:00 https://xintela.se/en/mfn_news/xintela-and-northx-biologics-sign-collaboration-framework-agreement/ 2025-11-20T16:31:49+00:00 https://xintela.se/mfn_news/xintela-och-northx-biologics-tecknar-ramavtal-for-samarbete/ 2025-11-20T16:31:49+00:00 https://xintela.se/en/mfn_news/xintela-obtains-us-patent-for-stem-cell-treatment/ 2025-11-20T16:31:49+00:00 https://xintela.se/mfn_news/xintela-erhaller-godkant-patent-i-usa-for-stamcellsbehandling/ 2025-11-20T16:31:49+00:00 https://xintela.se/mfn_news/kommunike-fran-extra-bolagsstamma-i-xintela-ab-publ/ 2025-11-20T16:31:49+00:00 https://xintela.se/en/mfn_news/xintela-ab-interim-report-january-september-2022/ 2025-11-20T16:31:49+00:00 https://xintela.se/en/mfn_news/xintela-year-end-report-2022/ 2025-11-20T16:31:49+00:00 https://xintela.se/mfn_news/xintela-ab-bokslutskommunike-2022/ 2025-11-20T16:31:49+00:00 https://xintela.se/en/mfn_news/communique-from-the-annual-general-meeting-of-xintela-ab-publ/ 2025-11-20T16:31:48+00:00 https://xintela.se/en/mfn_news/xintela-ab-publishes-annual-report-2022/ 2025-11-20T16:31:48+00:00 https://xintela.se/mfn_news/xintela-ab-publicerar-arsredovisning-for-2022/ 2025-11-20T16:31:48+00:00 https://xintela.se/mfn_news/kallelse-till-arsstamma-i-xintela-ab-publ-3/ 2025-11-20T16:31:48+00:00 https://xintela.se/en/mfn_news/xintela-has-started-last-dose-level-of-xstem-in-knee-osteoarthritis-clinical-study/ 2025-11-20T16:31:48+00:00 https://xintela.se/mfn_news/xintela-har-inlett-sista-dosnivan-med-xstem-i-klinisk-studie-for-knaartros/ 2025-11-20T16:31:48+00:00 https://xintela.se/en/mfn_news/xintela-ab-biostock-investor-meeting-with-xintela/ 2025-11-20T16:31:48+00:00 https://xintela.se/mfn_news/xintela-ab-biostock-investor-meeting-med-xintela/ 2025-11-20T16:31:48+00:00 https://xintela.se/en/mfn_news/xintela-completes-dosing-of-xstem-second-dose-level-in-knee-osteoarthritis-clinical-study/ 2025-11-20T16:31:48+00:00 https://xintela.se/mfn_news/xintela-har-genomfort-doseringen-pa-andra-dosnivan-av-xstem-i-den-kliniska-studien-for-knaartros/ 2025-11-20T16:31:48+00:00 https://xintela.se/en/mfn_news/xintela-ab-interim-report-january-march-2023/ 2025-11-20T16:31:47+00:00 https://xintela.se/mfn_news/xintela-ab-delarsrapport-januari-mars-2023/ 2025-11-20T16:31:47+00:00 https://xintela.se/mfn_news/xintela-genomfor-foretradesemission-av-units-om-cirka-123-msek/ 2025-11-20T16:31:47+00:00 https://xintela.se/mfn_news/kommunike-fran-arsstamma-i-xintela-ab-publ-3/ 2025-11-20T16:31:47+00:00 https://xintela.se/mfn_news/xintelas-foretradesemission-med-units-pagar-fram-till-den-19-juni-2023/ 2025-11-20T16:31:47+00:00 https://xintela.se/en/mfn_news/xintela-publishes-positive-preclinical-results-from-xstem-treatment-of-ards/ 2025-11-20T16:31:47+00:00 https://xintela.se/mfn_news/xintela-publicerar-positiva-prekliniska-resultat-med-xstem-for-behandling-av-ards/ 2025-11-20T16:31:47+00:00 https://xintela.se/mfn_news/xintelas-kliniska-studie-med-xstem-for-knaartros-fortskrider-val/ 2025-11-20T16:31:47+00:00 https://xintela.se/en/mfn_news/xintelas-clinical-study-with-xstem-for-knee-osteoarthritis-makes-good-progress/ 2025-11-20T16:31:47+00:00